JP2015514760A5 - - Google Patents

Download PDF

Info

Publication number
JP2015514760A5
JP2015514760A5 JP2015506995A JP2015506995A JP2015514760A5 JP 2015514760 A5 JP2015514760 A5 JP 2015514760A5 JP 2015506995 A JP2015506995 A JP 2015506995A JP 2015506995 A JP2015506995 A JP 2015506995A JP 2015514760 A5 JP2015514760 A5 JP 2015514760A5
Authority
JP
Japan
Prior art keywords
cells
therapeutic composition
retinal
esmv
eye
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015506995A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015514760A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/030733 external-priority patent/WO2013158258A1/en
Publication of JP2015514760A publication Critical patent/JP2015514760A/ja
Publication of JP2015514760A5 publication Critical patent/JP2015514760A5/ja
Pending legal-status Critical Current

Links

JP2015506995A 2012-04-16 2013-03-13 胚性幹細胞微小胞を用いる眼科治療法 Pending JP2015514760A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261624701P 2012-04-16 2012-04-16
US61/624,701 2012-04-16
PCT/US2013/030733 WO2013158258A1 (en) 2012-04-16 2013-03-13 Ocular therapeutics using embryonic system cell microvesicles

Publications (2)

Publication Number Publication Date
JP2015514760A JP2015514760A (ja) 2015-05-21
JP2015514760A5 true JP2015514760A5 (cg-RX-API-DMAC7.html) 2016-06-16

Family

ID=49383920

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015506995A Pending JP2015514760A (ja) 2012-04-16 2013-03-13 胚性幹細胞微小胞を用いる眼科治療法

Country Status (8)

Country Link
US (1) US20150079047A1 (cg-RX-API-DMAC7.html)
EP (1) EP2838995A4 (cg-RX-API-DMAC7.html)
JP (1) JP2015514760A (cg-RX-API-DMAC7.html)
KR (1) KR20150009541A (cg-RX-API-DMAC7.html)
AU (1) AU2013249786A1 (cg-RX-API-DMAC7.html)
CA (1) CA2870466A1 (cg-RX-API-DMAC7.html)
IL (1) IL235126A0 (cg-RX-API-DMAC7.html)
WO (1) WO2013158258A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101334404B1 (ko) * 2011-04-28 2013-12-12 포항공과대학교 산학협력단 배아줄기세포 유래의 인공 마이크로베시클을 이용한 역분화 유도만능줄기세포의 제조방법
US11653636B2 (en) * 2019-11-15 2023-05-23 University Of Ulsan Foundation For Industry Cooperation Method of making a rat model of retinal degeneration and rat model made thereby
JP7007770B1 (ja) * 2021-06-21 2022-02-10 パナジー株式会社 眼症状改善剤および眼症状の改善方法
KR20230129828A (ko) 2022-03-02 2023-09-11 포항공과대학교 산학협력단 안구 후방 질환 또는 손상의 예방 또는 치료용 조성물
CN117379533B (zh) * 2022-07-11 2026-06-26 暨南大学 NeuroD1在制备将视网膜穆勒胶质细胞转化为神经元的药物中的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824685A (en) * 1995-02-01 1998-10-20 The Johns Hopkins University School Of Medicine Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
CN1307300C (zh) * 2002-07-25 2007-03-28 斯克里普斯研究学院 造血干细胞和治疗新生血管性眼部疾病的方法
AU2003280824A1 (en) * 2002-11-15 2004-06-15 Fumihiko Ishikawa Method of organ regeneration
RU2403906C2 (ru) * 2005-02-24 2010-11-20 Дзе Скриппс Рисерч Инститьют Способ лечения ретинопатии при недоношенности и родственных ретинопатических заболеваний
BRPI0615974A2 (pt) * 2005-07-27 2011-05-31 University Of Florida Research Foundation, Inc., uso de choque térmico para tratar uma doença ocular em um indivìduo, método para recrutar uma célula-tronco para um tecido ocular de um indivìduo com necessidade da mesma, uso de choque térmico para tratar uma doença ou um distúrbio ocular em um indivìduo com necessidade do mesmo, uso de choque térmico para regenerar a retina em um indivìduo com necessidade do mesmo, uso de choque térmico para reparar os danos ao epitélio pgmentar da retina em um indivìduo com necessidade do mesmo, uso de choque térmico para tratar a degeneração macular em um indivìduo com necessidade do mesmo, composição farmacêutica para o recrutamento de células-tronco, composição farmacêutica para recrutamento de células-tronco em um tecido ocular, kit e método para identificar um agente que aumenta o recrutamento de células-tronco em um tecido ocular
GEP20135796B (en) * 2006-03-07 2013-04-10 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation
CN101854941B (zh) * 2007-10-29 2013-03-27 弗雷森纽斯医疗护理德国有限责任公司 衍生自干细胞的微泡(MVs)用于制备用于受损或损伤组织或器官的内皮/上皮再生的药物的用途、以及相关体外和体内方法
NZ586497A (en) * 2008-01-04 2012-07-27 Lydac Neuroscience Ltd Microvesicles
EP2486126B1 (en) * 2009-10-06 2017-12-06 SNU R & DB Foundation Method for differentiation into retinal cells from stem cells
EP2603592A2 (en) * 2010-08-13 2013-06-19 The University Court of the University of Glasgow Therapeutic uses of microvesicles and related micrornas
JP5872041B2 (ja) * 2011-08-16 2016-03-01 サムスン ライフ パブリック ウェルフェア ファンデーション 幹細胞由来微小胞を含む神経生成促進用組成物
US20160022743A1 (en) * 2012-05-31 2016-01-28 The Schepens Eye Research Institute, Inc. Human very small embryonic-like (vsel) stem cells for treatment of ocular disease

Similar Documents

Publication Publication Date Title
Luo et al. Harnessing the tunable cavity of nanoceria for enhancing Y-27632-mediated alleviation of ocular hypertension
Thanos et al. Role of crystallins in ocular neuroprotection and axonal regeneration
Pitha et al. Rho-kinase inhibition reduces myofibroblast differentiation and proliferation of scleral fibroblasts induced by transforming growth factor β and experimental glaucoma
Moura-Coelho et al. Rho kinase inhibitors—a review on the physiology and clinical use in Ophthalmology
Wohl et al. Neurogenic potential of stem/progenitor-like cells in the adult mammalian eye
Enyong et al. Caveolar and non-Caveolar Caveolin-1 in ocular homeostasis and disease
JP6981694B2 (ja) 選択された抗コリン作用性双性イオンの使用
JP2015509500A5 (cg-RX-API-DMAC7.html)
JP7716841B2 (ja) 黄斑変性症の新しい治療法
Jin et al. Multifunctional nanogel loaded with cerium oxide nanozyme and CX3CL1 protein: Targeted immunomodulation and retinal protection in uveitis rat model
Chohan et al. Müller stem cell dependent retinal regeneration
JP2016522830A5 (cg-RX-API-DMAC7.html)
CN102258518A (zh) 石杉碱甲在制备治疗青光眼和/或缺血诱发的视神经损伤的药物中的用途
CN103800325A (zh) 吡非尼酮的新用途
JP2014510115A (ja) 初期の緑内障における正常な視覚機能を回復するpacap(下垂体アデニル酸シクラーゼ活性化ポリペプチド)に基づく眼科用製剤
CN120227379A (zh) 芦可替尼在治疗年龄相关性黄斑变性中的应用
Zeppieri et al. Beyond the dusty fog: local eye drop therapy and potentially new treatment alternatives in pseudoexfoliative glaucoma
JP2020530459A5 (cg-RX-API-DMAC7.html)
Cornel et al. Novelties in medical treatment of glaucoma
Jiménez-Ortiz et al. Pharmacological treatments for the correction of presbyopia
Su et al. Evaluation of photodynamic therapy in idiopathic choroidal neovascularization
Khoroshilova-Maslova et al. Retinal changes after intravitreal injections of various concentrations of antiproliferative medication Melphalan: an experimental and morphological study
Daull et al. Efficacy evaluation of a cationic emulsion of cyclosporine in a mouse model of dry eye
Eskina et al. Efficacy of 0.2% brimonidine in combination therapy for patients with primary open-angle glaucoma and axial myopia
RU2620248C1 (ru) Способ устранения паралитического лагофтальма